Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

This study is ongoing, but not recruiting participants.

Study NCT00795418 Information provided by Novartis

First Received: November 10, 2008 Last Updated: May 10, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2010 (Final data collection date for primary outcome measure)